GlaxoSmithKline (NYSE:GSK) announced that Phase 3 clinical trial assessing asthma med Nucala (mepolizumab) for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) met both co-primary endpoints and all secondary endpoints.
• According to Bloomberg, Johnson & Johnson (NYSE:JNJ) has approached Actelion (OTCPK:ALIOY) about a potential takeover in a bid to boost its pharma business. Actelion's market valuation is currently close to $17 billion.
• AON (NYSE:AON) has agreed to acquire Admix, health and benefits brokerage and solutions firm. The company is based out of Brazil. The financial details of the deal have not been disclosed.